A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17609306

Download in:

View as

General Info

PMID
17609306